SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

UPDATED -- Benitec Biopharma Releases First Quarter 2027 Fiscal-Year Financial Results and Provides Operational Update

Positive interim clinical results from the ongoing BB-301 Phase 1b/2a study for dysphagic patients w

BNTC

Related stories